Mutual of America Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Sell
603,647
-5,809
-1% -$155K 0.19% 80
2025
Q4
$15.2M Sell
609,456
-5,792
-0.9% -$146K 0.16% 95
2025
Q3
$15.7M Sell
615,248
-35,785
-5% -$883K 0.17% 97
2025
Q2
$15.8M Sell
651,033
-7,028
-1% -$164K 0.17% 97
2025
Q1
$16.7M Sell
658,061
-19,866
-3% -$520K 0.19% 81
2024
Q4
$18M Sell
677,927
-18,929
-3% -$513K 0.19% 69
2024
Q3
$20.2M Sell
696,856
-16,921
-2% -$494K 0.21% 68
2024
Q2
$20M Sell
713,777
-25,729
-3% -$708K 0.22% 62
2024
Q1
$20.5M Sell
739,506
-15,141
-2% -$420K 0.22% 62
2023
Q4
$21.7M Sell
754,647
-34,509
-4% -$1.04M 0.25% 48
2023
Q3
$26.2M Sell
789,156
-49,820
-6% -$1.76M 0.32% 38
2023
Q2
$30.8M Buy
838,976
+7,952
+1% +$310K 0.35% 33
2023
Q1
$33.9M Buy
831,024
+431
+0.1% +$18.6K 0.4% 29
2022
Q4
$42.6M Buy
830,593
+23,320
+3% +$1.12M 0.53% 21
2022
Q3
$35.3M Buy
807,273
+11,998
+2% +$583K 0.48% 22
2022
Q2
$41.7M Buy
795,275
+14,606
+2% +$744K 0.53% 18
2022
Q1
$40.4M Buy
780,669
+40,213
+5% +$2.09M 0.43% 24
2021
Q4
$43.7M Buy
740,456
+5,445
+0.7% +$270K 0.44% 20
2021
Q3
$31.6M Buy
735,011
+5,040
+0.7% +$223K 0.31% 35
2021
Q2
$28.6M Buy
729,971
+9,151
+1% +$356K 0.28% 40
2021
Q1
$26.1M Buy
720,820
+21,367
+3% +$759K 0.27% 47
2020
Q4
$25.7M Sell
699,453
-59,533
-8% -$2.18M 0.29% 42
2020
Q3
$26.4M Sell
758,986
-39,017
-5% -$1.37M 0.35% 36
2020
Q2
$24.8M Buy
798,003
+2,939
+0.4% +$99.8K 0.35% 39
2020
Q1
$24.6M Buy
795,064
+11,161
+1% +$380K 0.41% 30
2019
Q4
$29.1M Buy
783,903
+4,398
+0.6% +$157K 0.37% 33
2019
Q3
$26.6M Sell
779,505
-1,119
-0.1% -$40.7K 0.37% 35
2019
Q2
$32.1M Buy
780,624
+1,068
+0.1% +$42.4K 0.45% 27
2019
Q1
$31.4M Sell
779,556
-21,855
-3% -$875K 0.46% 28
2018
Q4
$33.2M Sell
801,411
-96,588
-11% -$4.01M 0.55% 21
2018
Q3
$37.5M Buy
897,999
+57,161
+7% +$2.2M 0.53% 20
2018
Q2
$28.9M Buy
840,838
+36,881
+5% +$1.26M 0.43% 26
2018
Q1
$27.1M Buy
803,957
+14,142
+2% +$486K 0.42% 28
2017
Q4
$27.1M Buy
789,815
+25,487
+3% +$869K 0.41% 30
2017
Q3
$25.9M Sell
764,328
-2,368
-0.3% -$76.1K 0.42% 24
2017
Q2
$24.4M Sell
766,696
-116,646
-13% -$3.68M 0.42% 25
2017
Q1
$28.7M Sell
883,342
-9,405
-1% -$297K 0.51% 18
2016
Q4
$27.5M Buy
892,747
+46,062
+5% +$1.41M 0.52% 19
2016
Q3
$27.2M Buy
846,685
+37,245
+5% +$1.25M 0.55% 17
2016
Q2
$27M Sell
809,440
-29,308
-3% -$935K 0.58% 17
2016
Q1
$23.6M Buy
838,748
+1,567
+0.2% +$44.8K 0.52% 20
2015
Q4
$25.6M Buy
837,181
+3,970
+0.5% +$125K 0.58% 16
2015
Q3
$24.8M Buy
833,211
+7,771
+0.9% +$249K 0.59% 13
2015
Q2
$26.3M Sell
825,440
-4,024
-0.5% -$131K 0.57% 12
2015
Q1
$27.4M Sell
829,464
-3,099
-0.4% -$98.5K 0.6% 12
2014
Q4
$24.6M Sell
832,563
-931
-0.1% -$26.7K 0.55% 13
2014
Q3
$23.4M Buy
833,494
+6,082
+0.7% +$171K 0.56% 16
2014
Q2
$23.3M Sell
827,412
-18,039
-2% -$514K 0.55% 15
2014
Q1
$25.8M Sell
845,451
-21,351
-2% -$637K 0.62% 13
2013
Q4
$25.2M Sell
866,802
-7,303
-0.8% -$213K 0.62% 12
2013
Q3
$23.8M Buy
874,105
+11,307
+1% +$308K 0.65% 12
2013
Q2
$22.9M Buy
+862,798
New +$23.8M 0.68% 13

Other funds holding PFE

Mutual of America Capital Management's PFE Position: Q1 2026 in Review

Mutual of America Capital Management reduced its Pfizer (PFE) stake by 0.95% in Q1 2026, selling an estimated $155K and leaving 603,647 shares worth $17M. The position accounts for 0.19% of the portfolio, ranked #80.

Mutual of America Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.7M in Q4 2021. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mutual of America Capital Management held 603,647 shares of Pfizer worth $17M as of Q1 2026.
  • Mutual of America Capital Management sold 5,809 Pfizer shares in Q1 2026, an estimated $155K.
  • Pfizer made up 0.19% of Mutual of America Capital Management's portfolio in Q1 2026, its #80 holding.
  • Mutual of America Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Mutual of America Capital Management's Pfizer position peaked at $43.7M in Q4 2021.
  • 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.